Detailansicht
Modern Drug Synthesis
eBook - Wiley Series on Drug Synthesis
ISBN/EAN: 9781118701249
Umbreit-Nr.: 4624682
Sprache:
Englisch
Umfang: 376 S., 12.13 MB
Format in cm:
Einband:
Keine Angabe
Erschienen am 27.03.2013
Auflage: 1/2013
E-Book
Format: EPUB
DRM: Adobe DRM
- Zusatztext
- Following<i>Contemporary Drug Synthesis and The Art of Drug Synthesis</i> (Wiley, 2004 and 2007), two well-received works, is this new book that demystifies the process of modern drug discovery for practitioners and students. An enhanced introduction covers areas such as background, pharmacology, SAR, PK/PD, efficacy, and safety. Focusing on the advantages of process synthesis versus the discovery synthetic route, Modern Drug Synthesis features authoritative coverage by distinguished editors and authors (some chapter authors are the actual inventor of the drug) of twenty different drug molecules.
- Kurztext
- Following Contemporary Drug Synthesis and The Art of Drug Synthesis (Wiley, 2004 and 2007), two well-received works, is this new book that demystifies the process of modern drug discovery for practitioners and students. An enhanced introduction covers areas such as background, pharmacology, SAR, PK/PD, efficacy, and safety. Focusing on the advantages of process synthesis versus the discovery synthetic route, Modern Drug Synthesis features authoritative coverage by distinguished editors and authors (some chapter authors are the actual inventor of the drug) of twenty different drug molecules.
- Autorenportrait
- <b>JIE JACK LI</b> is a chemist at Bristol-Myers Squibb Company in Wallingford, Connecticut. He is the coauthor of various books, including<i>Palladium in Heterocyclic Chemistry, Name Reactions: A Collection of Detailed Reaction Mechanisms and Synthetic Applications, Name Reactions in Heterocyclic Chemistry, Contemporary Drug Synthesis, The Art of Drug Synthesis, Name Reactions for Functional Group Transformations, Name Reactions for Homologations, Parts 1 and 2,</i> and<i>Name Reactions for Carbocyclic Ring Formations.</i><p><b>DOUGLAS JOHNSON</b> is a medicinal chemist and project leader at Pfizer in Groton, Connecticut. He is a coauthor on more than forty publications and patents, including the books<i>The Art of Drug Synthesis and Contemporary Drug Synthesis.</i></p>